Utilization of psychotropic drugs in Serbia from 2006 to 2021: Patterns before and during the COVID-19 pandemic
The COVID-19 pandemic did not contribute to change in consumption of psychotropic drugs in Serbia. Still, the use of antidepressants, atypical antipsychotics, anxiolytics, sedatives, hypnotics, anti-dementia drugs and gabapentinoids increased from 2006 to 2021.
Authors
- Bojan Joksimović (ORCID: https://orcid.org/0000-0003-3794-2539)
- Dragan Živanović (ORCID: https://orcid.org/0000-0002-9880-2305)
- Marija Milić (ORCID: https://orcid.org/0000-0001-5575-0587)
- Ana Adamović (ORCID: https://orcid.org/0009-0009-6885-9528)
- Milena Stevanović (ORCID: https://orcid.org/0000-0003-4286-7334)
- Tatjana M. Gazibara (ORCID: https://orcid.org/0000-0002-9621-8375)
- Vladan Šaponjić
- Zorica Stanojević-Ristić (ORCID: https://orcid.org/0000-0003-2741-7984)
- Periša Simonović
- Jelena Filimonović (ORCID: https://orcid.org/0000-0002-2161-2394)
- Maja Stošić (ORCID: https://orcid.org/0000-0003-0478-1716)
- Jelena Dotlić (ORCID: https://orcid.org/0000-0001-9683-9561)
- Miljan Adamović (ORCID: https://orcid.org/0009-0009-9088-7576)
- Ivana Vukajlovic
- Marina Jelic
- Mirjana Stojanovic Tasic
- Jelena Perovic
- Danijela Nastic Simovic
- Anastasija Karapandzic
Institutions
- University of Kragujevac (RS)
- University of East Sarajevo (BA)
- University of Belgrade (RS)
- Univerzitetski Klinički Centar Srbije (RS)
- Educons University (RS)
- Institute of Public Health of Serbia (RS)
- Regulatory Agency for Electronic Communications and Postal Services (RS)
- Clinical Centre of Kragujevac (RS)
- University of Prishtina (XK)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1371/journal.pone.0330749
- Citations
- 1
- Primary Topic
- COVID-19 and Mental Health
- Type
- article
- Field-Weighted Citation Impact
- 2.31